Healthcare provider profile · identity verified

Bijo George

Nurse Practitioner · TEXAS CITY, TX · NPI 1821404831

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	366	65
Atorvastatin Calcium	Atorvastatin Calcium	314	63
Furosemide	Furosemide	289	64
Potassium Chloride	Potassium Chloride	236	58
Tramadol Hcl	Tramadol Hcl	178	47
Donepezil Hcl	Donepezil Hcl	176	41
Eliquis	Apixaban	175	26
Gabapentin	Gabapentin	166	42
Amlodipine Besylate	Amlodipine Besylate	164	42
Acetaminophen-Codeine	Acetaminophen With Codeine	154	31
Tamsulosin Hcl	Tamsulosin Hcl	152	27
Losartan Potassium	Losartan Potassium	148	30
Sertraline Hcl	Sertraline Hcl	141	39
Mirtazapine	Mirtazapine	139	42
Memantine Hcl	Memantine Hcl	136	32
Pantoprazole Sodium	Pantoprazole Sodium	136	29
Buspirone Hcl	Buspirone Hcl	128	36
Clopidogrel	Clopidogrel Bisulfate	128	24
Metoprolol Tartrate	Metoprolol Tartrate	126	29
Trazodone Hcl	Trazodone Hcl	125	40
Metformin Hcl	Metformin Hcl	113	21
Divalproex Sodium	Divalproex Sodium	107	22
Lisinopril	Lisinopril	93	19
Lorazepam	Lorazepam	79	23
Carvedilol	Carvedilol	76	22
Quetiapine Fumarate	Quetiapine Fumarate	76	19
Omeprazole	Omeprazole	74	22
Metoprolol Succinate	Metoprolol Succinate	71	20
Myrbetriq	Mirabegron	71	suppressed
Famotidine	Famotidine	64	16
Spironolactone	Spironolactone	64	13
Citalopram Hbr	Citalopram Hydrobromide	63	suppressed
Nystatin	Nystatin	58	32
Rosuvastatin Calcium	Rosuvastatin Calcium	56	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	55	14
Ondansetron Hcl	Ondansetron Hcl	54	37
Pregabalin	Pregabalin	52	12
Baclofen	Baclofen	51	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	50	39
Januvia	Sitagliptin Phosphate	50	suppressed
Cephalexin	Cephalexin	49	32
Lantus	Insulin Glargine,hum.Rec.Anlog	47	11
Permethrin	Permethrin	46	35
Gemtesa	Vibegron	44	suppressed
Allopurinol	Allopurinol	42	suppressed
Clonazepam	Clonazepam	42	15
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	42	25
Amiodarone Hcl	Amiodarone Hcl	39	14
Jardiance	Empagliflozin	39	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	39	suppressed
Duloxetine Hcl	Duloxetine Hcl	38	suppressed
Lactulose	Lactulose	37	18
Tradjenta	Linagliptin	37	suppressed
Pravastatin Sodium	Pravastatin Sodium	36	suppressed
Solifenacin Succinate	Solifenacin Succinate	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	32	20
Midodrine Hcl	Midodrine Hcl	32	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	24
Fluticasone Propionate	Fluticasone Propionate	30	17
Hydralazine Hcl	Hydralazine Hcl	30	suppressed
Nifedipine Er	Nifedipine	30	suppressed
Doxepin Hcl	Doxepin Hcl	29	suppressed
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Alprazolam	Alprazolam	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Levetiracetam	Levetiracetam	28	11
Simvastatin	Simvastatin	28	suppressed
Glimepiride	Glimepiride	26	suppressed
Estradiol	Estradiol	25	suppressed
Movantik	Naloxegol Oxalate	24	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	23	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	23	suppressed
Bumetanide	Bumetanide	21	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Dofetilide	Dofetilide	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Levofloxacin	Levofloxacin	21	18
Prednisone	Prednisone	21	15
Albuterol Sulfate Hfa	Albuterol Sulfate	20	13
Finasteride	Finasteride	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Sodium Chloride	0.9 % Sodium Chloride	20	16
Diltiazem Hcl	Diltiazem Hcl	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Risperidone	Risperidone	19	suppressed
Alendronate Sodium	Alendronate Sodium	18	suppressed
Celecoxib	Celecoxib	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	16
Benazepril Hcl	Benazepril Hcl	17	suppressed
Montelukast Sodium	Montelukast Sodium	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Meloxicam	Meloxicam	16	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	16	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	15	15
Ezetimibe	Ezetimibe	15	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	15	suppressed
Acetazolamide	Acetazolamide	14	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Methimazole	Methimazole	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Temazepam	Temazepam	14	suppressed
Ivermectin	Ivermectin	13	13
Aripiprazole	Aripiprazole	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Lacosamide	Lacosamide	12	suppressed
Mupirocin	Mupirocin	12	11
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Timolol Maleate	Timolol Maleate	12	suppressed
Benztropine Mesylate	Benztropine Mesylate	11	suppressed
Carbamazepine Er	Carbamazepine	11	suppressed
Digoxin	Digoxin	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	11	suppressed
Rhopressa	Netarsudil Mesylate	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error